It is extremely unlikely that the fall off in efficacy is as large as the limited data might imply. None of the other vaccines that produce similar immune repsonses suggest this, neither does antibod… (View Post)

It's probable that they will end up reversing the decision, so all this will have accomplished is a further delay. It's really not about whether or not a vaccine prevents COVID-19, where th… (View Post)

They are taking a pessimistic interpretation of the admittedly limited data and not approving the use of the vaccine for the very group that could benefit the most. That might be fine if this was any… (View Post)

It was probably the same chumps touting how the EU scheme was better value for money, by paying less for no vaccine. (View Post)

The fundamental problem with that argument is we got cracking whilst the EU were still talking. The first UK activity began a year ago, and the Vaccine Task Force was launched in April, and we have s… (View Post)